115
Views
4
CrossRef citations to date
0
Altmetric
Articles

Photostability study of agomelatine using UHPLC-DAD-MS/MS method. Kinetics, identification of the transformation products and in silico evaluation of toxicity

ORCID Icon & ORCID Icon

References

  • Tonnesen, H. H. Photostability of Drugs and Drug Formulations, 2nd ed; CRC Press: Boca Raton, 2004.
  • Isidori, M.; Lavorgna, M.; Nardelli, A.; Parrella, A.; Previtera, L.; Rubino, M. Ecotoxicity of Naproxen and Its Phototransformation Products. Sci. Total Environ. 2005, 348(1–3), 93–101. DOI:10.1016/j.scitotenv.2004.12.068.
  • Trawiński, J.; Skibiński, R. Studies on Photodegradation Process of Psychotropic Drugs: A Review. Environ. Sci. Pollut. Res. 2017, 24(2), 1152–1199. DOI:10.1007/s11356-016-7727-5.
  • Zupancic, M.; Guilleminault, C. Agomelatine. CNS Drugs 2006, 20(12), 981–992. DOI:10.2165/00023210-200620120-00003.
  • Buoli, M.; Grassi, S.; Serati, M.; Altamura, A.C. Agomelatine for the Treatment of Generalized Anxiety Disorder. Expert Opin. Pharmacother. 2017, 18(13), 1373–1379. DOI:10.1080/14656566.2017.1359257.
  • Richey, S.M.; Krystal, A.D. Pharmacological Advances in the Treatment of INSOMNIA. Curr. Pharm. Des. 2011, 17(15), 1471–1475. DOI:10.2174/138161211796197052.
  • Wang, X.; Zhang, D.; Liu, M.; Zhao, H.; Du, A.; Meng, L.; Liu, H. LC-MS/MS Method for the Determination of Agomelatine in Human Plasma and Its Application to a Pharmacokinetic Study. Biomed. Chromatogr. 2014, 28(2), 218–222. DOI: 10.1002/bmc.3008.
  • Li, M.; Tang, F.; Xie, F.; Lv, Y.; Yu, P.; Liu, Z.; Cheng, Z. Development and Validation a LC–MS/MS Method for the Simultaneous Determination of Agomelatine and Its Metabolites, 7-Desmethyl-Agomelatine and 3-Hydroxy-Agomelatine in Human Plasma: Application to a Bioequivalence Study. J. Chromatogr. B. 2015, 1003, 60–66. DOI:10.1016/j.jchromb.2015.09.018.
  • Degreef, M.; Nuijs, A.L.N. van; Maudens, K.E. Validation of a Simple, Fast Liquid Chromatography-Tandem Mass spectrometry Method for the Simultaneous Quantification of 40 Antidepressant Drugs or Their Metabolites in Plasma. Clin. Chim. Acta. 2018, 485, 243–257. DOI:10.1016/j.cca.2018.06.047.
  • Saracino, M.A.; Mercolini, L.; Carbini, G.; Volterra, V.; Quarta, A.L.; Amore, M.; Raggi, M.A. Multi-Matrix Assay of the First Melatonergic Antidepressant Agomelatine by Combined Liquid Chromatography-Fluorimetric Detection and Microextraction by Packed Sorbent. J. Pharm. Biomed. Anal. 2014, 95, 61–67. DOI:10.1016/j.jpba.2014.02.005.
  • Steuer, A.E.; Poetzsch, M.; Koenig, M.; Tingelhoff, E.; Staeheli, S.N.; Roemmelt, A.T.; Kraemer, T. Comparison of Conventional Liquid Chromatography–Tandem Mass Spectrometry Versus Microflow Liquid Chromatography–Tandem Mass Spectrometry Within the Framework of Full Method Validation for Simultaneous Quantification of 40 Antidepressants and Neuroleptics in Whole Blood. J. Chromatogr. A 2015, 1381, 87–100. DOI:10.1016/j.chroma.2014.12.084.
  • Simonin, G.; Bru, L.; Lelièvre, E.; Jeanniot, J.-P.; Bromet, N.; Walther, B.; Boursier-Neyret, C. Determination of Melatonin in Biological Fluids in the Presence of the Melatonin Agonist S 20098: Comparison of Immunological Techniques and GC-MS Methods. J. Pharm. Biomed. Anal. 1999, 21(3), 591–601. DOI: 10.1016/S0731-7085(99)00150-8.
  • Mathrusri Annapurna, M.; Venkatesh, B. Novel Stability Indicating RP-HPLC Method for the Determination of Agomelatine - A Novel Antidepressant. J. Chem. Pharm. Sci. 2015, 8(3), 502–508.
  • Annapurna, M.M.; Venkatesh, B. Development and Validation of Stability Indicating Liquid Chromatographic Method for the Quantification of Agomelatine. Int. J. Pharm. Technol. 2016, 8(3), 17516–17527.
  • Abdelrahman, M.M.; Naguib, I.A.; El Ghobashy, M.R.; Ali, N.A. Stability-Indicating HPLC and HPTLC Methods for Determination of Agomelatine and its Degradation Products. J. Chromatogr. Sci. 2018, 56(4), 317–326. DOI:10.1093/chromsci/bmx114.
  • Indumathi, K.V.S.; Someshwara Rao, N.; Rao, B.M. Forced Degradation, Identification and Characterization of Impurities of Agomelatine Using Chromatographic and Spectroscopic Techniques. Res. J. Pharm. Biol. Chem. Sci. 2015, 6(1), 1112–1126.
  • Naguib, I.A.; Abdelrahman, M.M.; El Ghobashy, M.R.; Ali, N.A. Least-Squares Regression and Spectral Residual Augmented Classical Least-Squares Chemometric Models for Stability-Indicating Analysis of Agomelatine and its Degradation Products: A Comparative Study. J. AOAC Int. 2016, 99(2), 386–395. DOI:10.5740/jaoacint.15-0286.
  • Ibrahim, F.; El‐Deen, A.K.; Shimizu, K. Application of Quinone-Based Fluorophore and Native Fluorescence for the Spectrofluorimetric Determination of Agomelatine in Dosage Form: Identification of Acidic and Alkaline- Induced Degradation Products by LC–MS/TOF. Luminescence 2018, 33(1), 225–231. DOI:10.1002/bio.3405.
  • El-Shaheny, R.N. Evaluation of Agomelatine Stability Under Different Stress Conditions Using an HPLC Method with Fluorescence Detection: Application to the Analysis of Tablets and Human Plasma. Luminescence 2014, 29(7), 920–928. DOI: 10.1002/bio.2642.
  • Elkhoudary, M.M.; Naguib, I.A.; Abdel Salam, R.A.; Hadad, G.M. Comparison between Two Linear Supervised Learning Machines’ Methods with Principle Component Based Methods for the Spectrofluorimetric Determination of Agomelatine and Its Degradants. J. Fluoresc. 2017, 27(3), 1149–1160. DOI: 10.1007/s10895-017-2050-1.
  • International Conference on Harmonization of Technical Requirements for Registeration of Pharmaceuticals for Human Use (1996) STABILITY TESTING: - Q1B_Guideline.pdf. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1B/Step4/Q1B_Guideline.pdf (accessed Jul 7, 2016).
  • Trawiński, J.; Skibiński, R.; Komsta, Ł. Comparison of ESI and APCI Sources in Q-TOF Mass Spectrometer in Photodegradation Study of Selected Psychotropic Drugs. Acta Chromatogr. 2017, 29(2), 161–172. DOI:10.1556/1326.2017.29.2.2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.